Vineel Bhatlapenumarthi

Dr. Vineel Bhatlapenumarthi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2021 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
VBVineel Bhatlapenumarthi
Vineel Bhatlapenumarthi
APAnannya Patwari
Anannya Patwari
AHAntoine J. Harb
Antoine J. Harb

21 August 2020 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
APAnannya Patwari
Anannya Patwari
VBVineel Bhatlapenumarthi
Vineel Bhatlapenumarthi
SPSheila K. Pascual
Sheila K. Pascual
We report here a rare case of atypical posterior reversible encephalopathy syndrome (PRES) due to oral tyrosine kinase inhibitor cabozantinib. No case reports of such have been found in our literature search. The patient, a 70-year-old female with metastatic renal cell cancer on oral tyrosine kinase inhibitor cabozantinib, was brought into the emergency room because of confusion and seizures, found to have elevated blood pressure and atypical MRI findings consistent with PRES due to cabozantinib.

1 January 2020 in Journal of Hematology
Verified
Journal Article
Open access
VBVineel Bhatlapenumarthi
Vineel Bhatlapenumarthi
APAnannya Patwari
Anannya Patwari
SPSheila Karina Pascual
Sheila Karina Pascual
We present here a rare and unusual presentation of angioimmunoblastic T-cell lymphoma with non-necrotizing granuloma of bone marrow. We did not find any case reports of such case in our literature search. A 77-year-old man presented with shortness of breath, generalized weakness, fatigue and weight loss. Laboratory data revealed elevated white count, low platelets and anemia. Imaging studies revealed generalized lymphadenopathy. A bone marrow biopsy showed hypercellular marrow with non-caseating granuloma which was non-diagnostic and lymph node biopsy showed angioimmunoblastic T-cell lymphoma.